AngioScore, Inc. Files Patent Infringement Suit Against TriReme Medical Inc. and Quattro
FREMONT, Calif.--(BUSINESS WIRE)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today filed suit against TriReme Medical, Inc. (“TriReme”) and Quattro Vascular Pte Ltd (“Quattro”)for infringement of United States Patents Nos. 7,691,119 and 7,931,663 which cover specialized angioplasty balloon catheters and their use.